专家文章 | 祝荫

搜索
登录

热心肠智库专家文章 | 祝荫

2024

CAMetal-Organic Framework Based Mucoadhesive Nanodrugs for Multifunction Helicobacter Pylori Targeted Eradication, Inflammation Regulation and Gut Flora Protection

SMALL, 10.1002/smll.202308286

2023

CABibliometric analysis of pancreatic diseases and gut microbiota research from 2002 to 2022

Heliyon, 10.1016/j.heliyon.2023.e23483

CAElevated CK-MB levels are associated with adverse clinical outcomes in acute pancreatitis: a propensity score-matched study

FRONT MED-LAUSANNE, 10.3389/fmed.2023.1256804

CADefined, low threshold for caesarean section and multidisciplinary team management improves fetal outcome from acute pancreatitis in pregnancy

PANCREATOLOGY, 10.1016/j.pan.2023.05.009

CANomogram development and validation for predicting minimally invasive step-up approach failure in infected necrotizing pancreatitis patients: a retrospective cohort study

INT J SURG, 10.1097/JS9.0000000000000415

CAYAP and β-catenin cooperate to drive H. pylori-induced gastric tumorigenesis

Gut Microbes, 10.1080/19490976.2023.2192501

CAApplication of biomaterials in the eradication of Helicobacter pylori: A bibliometric analysis and overview

FMICB, 10.3389/fmicb.2023.1081271

CAApplication of biomaterials in the eradication of Helicobacter pylori: A bibliometric analysis and overview

FMICB, 10.3389/fmicb.2023.1081271

CASerum triglyceride levels are associated with recurrence in patients with acute hypertriglyceridemic pancreatitis

FRONT MED-LAUSANNE, 10.3389/fmed.2023.1079637

CAPancreatic Organoids: A Frontier Method for Investigating Pancreatic-Related Diseases

IJMS, 10.3390/ijms24044027

CA14-day pantoprazole- and amoxicillin-containing high-dose dual therapy for Helicobacter pylori eradication in elderly patients: A prospective, randomized controlled trial

FPHAR, 10.3389/fphar.2023.1096103

CAFourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study

Front Immunol, 10.3389/fimmu.2022.1049908

2022

CAA positive feedback loop of the TAZ/β-catenin axis promotes Helicobacter pylori-associated gastric carcinogenesis

FMICB, 10.3389/fmicb.2022.1065462

CAA positive feedback loop of the TAZ/β-catenin axis promotes Helicobacter pylori-associated gastric carcinogenesis

FMICB, 10.3389/fmicb.2022.1065462

CAThe management of Helicobacter pylori infection and prevention and control of gastric cancer in China

FCIMB, 10.3389/fcimb.2022.1049279

CAThe management of Helicobacter pylori infection and prevention and control of gastric cancer in China

FCIMB, 10.3389/fcimb.2022.1049279

CARecurrence for patients with first episode of hypertriglyceridemia-induced acute pancreatitis: A prospective cohort study

J CLIN LIPIDOL, 10.1016/j.jacl.2022.11.006

FAProbiotics modulate gastrointestinal microbiota after Helicobacter pylori eradication: A multicenter randomized double-blind placebo-controlled trial

Front Immunol, 10.3389/fimmu.2022.1033063

点击查看热心肠日报解读

FAProbiotics modulate gastrointestinal microbiota after Helicobacter pylori eradication: A multicenter randomized double-blind placebo-controlled trial

Front Immunol, 10.3389/fimmu.2022.1033063

点击查看热心肠日报解读

CATreatment of refractory Helicobacter pylori infection: A new challenge for clinicians

FMICB, 10.3389/fmicb.2022.998240